Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion type Assertion NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_head.
- NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion description "[The knockdown of CXCL8/Cxcl2 receptors (CXCR1/Cxcr1 and Cxcr2) reduced MTX-induced CRT exposure in both human and murine cancer cells, as well as the capacity of the latter-on exposure to MTX-to elicit an anticancer immune response in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_provenance.
- NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion evidence source_evidence_literature NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_provenance.
- NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion SIO_000772 23787997 NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_provenance.
- NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion wasDerivedFrom befree-20150227 NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_provenance.
- NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_assertion wasGeneratedBy ECO_0000203 NP502839.RAUsE3mfnPJgJS8Po2z6_jfVpAsDwEbhT7fkOvvlLYQOc130_provenance.